Document Type : Original articles


1 Department of Medicine (Rheumatology), Al-Ramadi Teaching Hospital, Anbar Health Directorate, Ramadi, Anbar, Iraq.

2 Department of Medicine (Rheumatology), College of Medicine, University of Baghdad, Baghdad, Iraq.

3 Department of Medicine (Rheumatology), Imam Al Hussein Medical City Hospital, Karbala Health Directorate, Karbala, Iraq.


Background: Gout is the most common type of inflammatory arthritis in men and postmenopausal women.The incidence and prevalence of hyperuricemia and gout were increased all over the world even among developed countries.
Materials and methods: A cross-sectional study was conducted at the Rheumatology Unit of Baghdad Teaching Hospital in Medical City, Baghdad, Iraq from October 2020 to April 2021. A total of 247 subjects were included in the study. Data were collected using a pre-constructed data collection sheet by face-to-face individual interviews. The sheet includes demographic characteristics, gout-related questions regarding the etiology, suspected predisposing agents, complications, diagnostic methods, food-related, clinical manifestations among studied cases, and attitudes of the gout patients among the study sample.
Results: Of 247 subjects, there were 67.2% (n = 166) males, 27.9 (n = 69) from the age group 40-49 years, 36.4% (n = 90) from Baghdad city, 25.5% (n = 63) university graduates, 19.9% with good income, 70.5 (174) employed, 221 (89.5%) married, 85% (n = 210) non-smokers, and 8.9% (n = 22) with family history of gout. Overall, 59 (23.9%) of the participants had a high level of awareness whereas low awareness levels accounted for 41.3% (n = 102). The awareness level showed a statistically significant association with education level, occupation, economic status, smoking habit, family history of gout, and patients with gout (P-value < 0.05).
Conclusion: There was a high proportion (41.3%) of the participants with a low level of awareness about gout and hyperuricemia. The awareness level among the participants was related to the education level, occupation, economic status, smoking habit, family history of gout, and patients with gout.


Main Subjects

[1]      J. Maiuolo, F. Oppedisano, S. Gratteri, C. Muscoli, and V. Mollace, “Regulation of uric acid metabolism and excretion,” Int. J. Cardiol., vol. 213, pp. 8–14, 2016.
[2]      M. Jin et al., “Uric acid, hyperuricemia and vascular diseases,” Front. Biosci. a J. virtual Libr., vol. 17, p. 656, 2012.
[3]      A. Sidari and E. Hill, “Diagnosis and treatment of gout and pseudogout for everyday practice,” Prim. Care Clin. Off. Pract., vol. 45, no. 2, pp. 213–236, 2018.
[4]      C.-F. Kuo, M. J. Grainge, W. Zhang, and M. Doherty, “Global epidemiology of gout: prevalence, incidence and risk factors,” Nat. Rev. Rheumatol., vol. 11, no. 11, pp. 649–662, 2015.
[5]      J. A. Singh, “Racial and gender disparities among patients with gout,” Curr. Rheumatol. Rep., vol. 15, no. 2, p. 307, 2013.
[6]      J. H. Jung et al., “Metabolic syndrome: prevalence and risk factors in Korean gout patients,” Korean J. Intern. Med., vol. 33, no. 4, p. 815, 2018.
[7]      H. K. Choi, L. C. Soriano, Y. Zhang, and L. A. G. Rodríguez, “Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study,” Bmj, vol. 344, 2012.
[8]      C.-F. Kuo et al., “Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan,” Ann. Rheum. Dis., vol. 74, no. 2, pp. 369–374, 2015.
[9]      S. P. Juraschek, A. C. Gelber, H. K. Choi, L. J. Appel, and E. R. Miller III, “Effects of the Dietary Approaches to Stop Hypertension (DASH) diet and sodium intake on serum uric acid,” Arthritis Rheumatol., vol. 68, no. 12, pp. 3002–3009, 2016.
[10]    S. K. Rai, T. T. Fung, N. Lu, S. F. Keller, G. C. Curhan, and H. K. Choi, “The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study,” bmj, vol. 357, 2017.
[11]    S. J. Lee et al., “Perceptions of disease and health-related quality of life among patients with gout,” Rheumatology, vol. 48, no. 5, pp. 582–586, 2009.
[12]    N. Martini et al., “Living with gout in New Zealand: an exploratory study into people’s knowledge about the disease and its treatment,” JCR J. Clin. Rheumatol., vol. 18, no. 3, pp. 125–129, 2012.
[13]    A. A. Atalla, M. G. Albuqami, M. A. Albogami, A. K. Alharthi, and T. D. Altowairqi, “Awareness of gout disease among adult population in Taif city,” Int. J. Med. Dev. Ctries., vol. 4, no. 2, pp. 365–369, 2020.
[14]    Y. Zhu, B. J. Pandya, and H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008,” Arthritis Rheum., vol. 63, no. 10, pp. 3136–3141, 2011.
[15]    M. Kuwabara, “Hyperuricemia, cardiovascular disease, and hypertension,” Pulse, vol. 3, no. 3–4, pp. 242–252, 2015.
[16]    L. Bai, J.-B. Zhou, T. Zhou, R. B. Newson, and M. A. Cardoso, “Incident gout and weight change patterns: a retrospective cohort study of US adults,” Arthritis Res. Ther., vol. 23, no. 1, pp. 1–9, 2021.
[17]    Y. Zhang et al., “Purine-rich foods intake and recurrent gout attacks,” Ann. Rheum. Dis., vol. 71, no. 9, pp. 1448–1453, 2012.
[18]    M. Kakutani-Hatayama et al., “Nonpharmacological management of gout and hyperuricemia: hints for better lifestyle,” Am. J. Lifestyle Med., vol. 11, no. 4, pp. 321–329, 2017.
[19]    I. M. M. Alshammari and M. A. Mujtaba, “Public Knowledge and Awareness about Gout: A Cross-sectional Study in Qatar,” J. Pharm. Res. Int., pp. 1–11, 2017.
[20]    T. Neogi, C. Chen, J. Niu, C. Chaisson, D. J. Hunter, and Y. Zhang, “Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study,” Am. J. Med., vol. 127, no. 4, pp. 311–318, 2014.
[21]    T. Sugie, T. Imatou, M. Miyazaki, and H. Une, “The effect of alcoholic beverage type on hyperuricemia in Japanese male office workers,” J. Epidemiol., vol. 15, no. 2, pp. 41–47, 2005.
[22]    B. Spaetgens, T. Pustjens, L. E. J. M. Scheepers, H. J. E. M. Janssens, S. van der Linden, and A. Boonen, “Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice,” Clin. Rheumatol., vol. 35, no. 8, pp. 2053–2061, 2016.
[23]    C. Ben Salem, R. Slim, N. Fathallah, and H. Hmouda, “Drug-induced hyperuricaemia and gout,” Rheumatology, vol. 56, no. 5, pp. 679–688, 2017.
[24]    A. J. Landgren et al., “Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study,” Arthritis Res. Ther., vol. 19, no. 1, pp. 1–9, 2017.
[25]    A. NGAYIMBESHA, J. B. BIZIMANA, and M. S. GAKIMA, “Burundi Population Awareness about Gout and the Pivotal Role Played by Physical Exercise in Prevent and Managing Gout Relating Prob-lems,” Int J Sport. Exerc Med, vol. 5, p. 139, 2019.
[26]    L. R. Harrold, K. M. Mazor, D. Peterson, N. Naz, C. Firneno, and R. A. Yood, “Patients’ knowledge and beliefs concerning gout and its treatment: a population based study,” BMC Musculoskelet. Disord., vol. 13, no. 1, pp. 1–8, 2012.